Marksans Pharma Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Total Qtr Revenue cr | 891.29 | ||||
| Other Income Qtr Cr | 35.17 | ||||
| Operating Revenues Qtr | 856.11 | ||||
Loading chart... | |||||
Operating Expenses Qtr | 660.69 | ||||
Operating Profit Qtr | 195.42 | ||||
EBITDA Qtr Cr | 230.60 | ||||
Depreciation Qtr | 24.29 | ||||
Net Profit Qtr | 148.13 | ||||
Basic EPS Qtr | 3.27 | ||||